Bloomage Biotech's controlling shareholder exceeds share increase target

Bloomage Biotechnology Corporation (Bloomage Biotech) announced that its controlling shareholder, Bloomage Sun-Up Investment Co., Ltd., has made significant progress in its share increase plan. As of September 5, 2025, Bloomage Sun-Up has cumulatively increased its holdings by 3,496,931 shares through centralized bidding on the Shanghai Stock Exchange, representing 0.73% of the company's total share capital. The total amount spent on these shares reached RMB 200,682,204.43.

This amount has exceeded the lower limit of the initial target range of RMB 200 million, set forth in the announcement on August 8, 2025. The original plan, spanning six months from August 8, 2025, aimed to increase holdings by RMB 200 million to RMB 300 million, not exceeding 1% of total share capital, with a share price not exceeding RMB 70 per share.

The share increase plan is still ongoing, and Bloomage Sun-Up intends to continue executing the remaining portion of the plan using its own or self-raised funds. The company noted potential risks for the full execution of the plan due to market changes or unforeseen factors.